Dallas, Texas; and Stanford, Calif. From the Department of Plastic Surgery, University of Texas Southwestern Medical Center, and the Department of Surgery, Division of Plastic Surgery, Stanford University School of Medicine.
Plast Reconstr Surg. 2010 Dec;126(6):1936-1946. doi: 10.1097/PRS.0b013e3181f44790.
The recognition that fat contains stem cells has driven further examination into the potential uses of fat and adipose-derived stem cells in a wide number of clinical situations. New information about the harvesting, isolation, and subsequent differentiation properties of isolated adipose-derived stem cells has led to new research into novel tissue-engineered constructs and the transformation of adipose-derived stem cells to induced pluripotent stem cells. Clinically, use of fat grafts and adipose-derived stem cells worldwide and in the United States has dramatically increased in parallel to questions concerning the safety and efficacy of adipose-derived stem cell-based treatments. Currently, the U.S. Food and Drug Administration has not approved the use of isolated adipose-derived stem cells for medical indications.
人们认识到脂肪中含有干细胞,这促使人们进一步研究脂肪和脂肪来源的干细胞在许多临床情况下的潜在用途。关于分离的脂肪来源干细胞的采集、分离和随后的分化特性的新信息,导致了对新型组织工程构建体和将脂肪来源干细胞转化为诱导多能干细胞的新研究。在临床上,脂肪移植和脂肪来源干细胞在全球和美国的使用与对脂肪来源干细胞治疗的安全性和有效性的质疑同步大幅增加。目前,美国食品和药物管理局尚未批准将分离的脂肪来源干细胞用于医疗适应症。